Papers associated with slc22a5

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening., Kadoguchi M, Arakawa H, Honda R, Hotta K, Shirasaka Y, Deguchi Y, Tamai I., Pharm Res. July 1, 2022; 39 (7): 1549-1559.
	Comprehensive Substrate Characterization of 22 Antituberculosis Drugs for Multiple Solute Carrier (SLC) Uptake Transporters In Vitro., Parvez MM, Kaisar N, Shin HJ, Lee YJ, Shin JG., Antimicrob Agents Chemother. August 27, 2018; 62 (9):
	Transport of 3-fluoro-L-α-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [(18)F]FAMT positron emission tomography., Wei L, Tominaga H, Ohgaki R, Wiriyasermkul P, Hagiwara K, Okuda S, Kaira K, Kato Y, Oriuchi N, Nagamori S, Kanai Y., J Pharmacol Sci. February 1, 2016; 130 (2): 101-9.
	Carnitine precursor γ-butyrobetaine is a novel substrate of the Na(+)- and Cl(-)-dependent GABA transporter Gat2., Nakanishi T, Fukuyama Y, Fujita M, Shirasaka Y, Tamai I., Drug Metab Pharmacokinet. January 1, 2011; 26 (6): 632-6.
	Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters., Hu S, Chen Z, Franke R, Orwick S, Zhao M, Rudek MA, Sparreboom A, Baker SD., Clin Cancer Res. October 1, 2009; 15 (19): 6062-9.
	Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice., Kano T, Kato Y, Ito K, Ogihara T, Kubo Y, Tsuji A., Drug Metab Dispos. May 1, 2009; 37 (5): 1009-16.
	Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+)., Srinivas SR, Prasad PD, Umapathy NS, Ganapathy V, Shekhawat PS., Am J Physiol Gastrointest Liver Physiol. November 1, 2007; 293 (5): G1046-53.
	Cloning and functional characterization of a novel up-regulator, cartregulin, of carnitine transporter, OCTN2., Nagai K, Takikawa O, Kawakami N, Fukao M, Soma T, Oda A, Nishiya T, Hayashi M, Lu L, Nakano M, Kajita E, Fujita H, Miwa S., Arch Biochem Biophys. August 1, 2006; 452 (1): 29-37.
	Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone., Iwanaga T, Kobayashi D, Hirayama M, Maeda T, Tamai I., Drug Metab Dispos. December 1, 2005; 33 (12): 1791-5.
	Na+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes., Nakanishi T, Hatanaka T, Huang W, Prasad PD, Leibach FH, Ganapathy ME, Ganapathy V., J Physiol. April 15, 2001; 532 (Pt 2): 297-304.
	Transport of L-carnitine in isolated cerebral cortex neurons., Wawrzeńczyk A, Sacher A, Mac M, Nałecz MJ, Nałecz KA., Eur J Biochem. April 1, 2001; 268 (7): 2091-8.
	Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2., Wagner CA, Lükewille U, Kaltenbach S, Moschen I, Bröer A, Risler T, Bröer S, Lang F., Am J Physiol Renal Physiol. September 1, 2000; 279 (3): F584-91.
	Characterization of L-carnitine transport into rat skeletal muscle plasma membrane vesicles., Berardi S, Stieger B, Hagenbuch B, Carafoli E, Krähenbühl S., Eur J Biochem. April 1, 2000; 267 (7): 1985-94.

???pagination.result.page??? 1